Oxford BioMedica plc  

(Public, LON:OXB)   Watch this stock  
Find more results for OXB
8.00
Feb 26 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range     -
52 week 1.77 - 10.12
Open     -
Vol / Avg. 0.00/7.39M
Mkt cap 207.82M*
P/E     -
Div/yield     -
EPS -0.01*
Shares 2.57B
Beta     -
Inst. own     -
*GBP
Mar 9, 2015
Oxford BioMedica PLC at ROTH Conference - 9:00PM GMT - Add to calendar
Jan 13, 2015
Oxford BioMedica PLC at EBD Biotech Showcase
  

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -101.57% -206.44%
Operating margin -114.62% -238.57%
EBITD margin - -218.72%
Return on average assets -43.98% -58.30%
Return on average equity -57.70% -77.75%
Employees 95 -
CDP Score - -

Address

The Oxford Science Park Medawar Centre Robert Robinson Avenue
OXFORD, OX4 4GA
United Kingdom - Map
+44-1865-783000 (Phone)
+44-1865-783001 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Oxford Biomedica PLC is a United Kingdom-based biopharmaceutical company. The Company is engaged in advanced therapy medicinal products. The Company designs, develops and manufactures gene-based medicines and therapeutic vaccines. The Company's technology platform includes LentiVector gene delivery technology, which has specific advantages for targeting diseases of the eye and central nervous system and a tumour antigen (5T4), which is a target for anti-cancer therapy. Its product pipeline addresses diseases, including ocular diseases, neurodegenerative disorders and cancer.

Officers and directors

John Dawson Chief Executive Officer, Executive Director
Age: 54
Tim Watts Chief Financial Officer, Company Secretary, Executive Director
Age: 56
Peter Nolan Senior Vice President - Commercial Development, Executive Director
Age: 60
Paul Blake M.D. Chief Development Officer, Director
Age: 66
Nick Rodgers Non-Executive Independent Chairman of the Board
Age: 55
Andrew J. Heath M.D., Ph.D. Non-Executive Deputy Chairman of the Board, Senior Independent Director
Age: 64
Martin Diggle Non-Executive Director
Age: 52